Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$614M |
| 2 |
Apple
AAPL
|
+$443M |
| 3 |
BLD
TopBuild
BLD
|
+$391M |
| 4 |
SPCX
SpaceX
SPCX
|
+$329M |
| 5 |
Penumbra
PEN
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.96B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
SNDK
Sandisk
SNDK
|
+$88M |
| 4 |
Southern Company
SO
|
+$80.6M |
| 5 |
PPL
PPL Corp
PPL
|
+$74.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Industrials | 13.64% |
| 3 | Consumer Discretionary | 9.5% |
| 4 | Healthcare | 7.9% |
| 5 | Financials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
El Pollo Loco
LOCO
$488M
| $304K | ﹤0.01% |
+17,901
| New | +$256K |
|
1352
MBIA
MBI
$250M
| $300K | ﹤0.01% |
46,010
+12,639
| +38% | +$76.2K |
|
|
CHCT
1353
Community Healthcare Trust
CHCT
$426M
| $300K | ﹤0.01% |
+16,392
| New | +$285K |
|
1354
Lucid Motors
LCID
$2.17B
| $300K | ﹤0.01% |
44,780
+11,110
| +33% | +$71.7K |
|
1355
MarineMax
HZO
$1.15B
| $299K | ﹤0.01% |
+8,177
| New | +$263K |
|
1356
Neuropace
NPCE
$482M
| $298K | ﹤0.01% |
+18,770
| New | +$302K |
|
1357
Digimarc Corp
DMRC
$138M
| $298K | ﹤0.01% |
+36,251
| New | +$341K |
|
1358
Life Time Group Holdings
LTH
$10.1B
| $298K | ﹤0.01% |
7,294
-55,387
| -88% | -$1.76M |
|
1359
Kopin
KOPN
$937M
| $293K | ﹤0.01% |
+65,359
| New | +$285K |
|
1360
Wayfair
W
$13.9B
| $292K | ﹤0.01% |
+3,156
| New | +$232K |
|
1361
Sherwin-Williams
SHW
$84.1B
| $291K | ﹤0.01% |
+846
| New | +$270K |
|
1362
CALL
Real Brokerage
REAX
$575M
| $291K | ﹤0.01% |
+160,000
| New | +$325K |
|
|
PPTA
1363
Perpetua Resources
PPTA
$3.21B
| $290K | ﹤0.01% |
+13,954
| New | +$379K |
|
1364
Clearfield
CLFD
$374M
| $289K | ﹤0.01% |
7,274
-18,884
| -72% | -$692K |
|
1365
Priority Technology Holdings
PRTH
$462M
| $287K | ﹤0.01% |
+42,992
| New | +$249K |
|
1366
Krispy Kreme
DNUT
$623M
| $287K | ﹤0.01% |
+81,204
| New | +$290K |
|
|
IMSR
1367
Terrestrial Energy
IMSR
$590M
| $285K | ﹤0.01% |
+40,205
| New | +$297K |
|
1368
FirstService
FSV
$6.35B
| $284K | ﹤0.01% |
+2,000
| New | +$277K |
|
|
UPB
1369
Upstream Bio Inc
UPB
$382M
| $284K | ﹤0.01% |
41,045
-50,386
| -55% | -$422K |
|
|
TII
1370
Titan Mining Corp
TII
$279M
| $282K | ﹤0.01% |
+128,723
| New | +$320K |
|
|
MCHB
1371
Mechanics Bancorp
MCHB
$3.59B
| $280K | ﹤0.01% |
+17,628
| New | +$264K |
|
1372
Oceaneering
OII
$5.28B
| $277K | ﹤0.01% |
+6,827
| New | +$257K |
|
1373
W&T Offshore
WTI
$592M
| $277K | ﹤0.01% |
87,815
-71,191
| -45% | -$264K |
|
1374
iShares MSCI Taiwan ETF
EWT
$11.2B
| $276K | ﹤0.01% |
+2,543
| New | +$238K |
|
1375
Larimar Therapeutics
LRMR
$434M
| $276K | ﹤0.01% |
90,413
+63,968
| +242% | +$254K |
|
Similar funds
Michael Gelband's Q2 2026 Portfolio in Review
As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.
- Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
- Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
- Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
- Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
- Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
- Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
- Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.